A federal appeals court has allowed West Virginia to continue blocking Medicaid coverage for gender-affirming surgeries, marking a significant development in the widening legal fight over transgender healthcare across the United States.
The ruling came from the U.S. Court of Appeals for the Fourth Circuit, where a three-judge panel concluded that the state’s law targets specific medical procedures rather than a particular group of people. Because of that distinction, the court determined the measure does not violate federal anti-discrimination protections or constitutional guarantees of equal protection.
The dispute centers on a state law enacted in 2004 that excludes certain gender-affirming surgeries from Medicaid coverage. Medicaid, a joint federal-state insurance program designed to support low-income residents, is used by millions of Americans to access healthcare.
A lower court had previously sided with a transgender woman challenging the restriction, finding that the policy amounted to discrimination. But the appellate panel reversed that outcome, emphasizing that the statute focuses on procedures rather than identity.
In its reasoning, the court pointed to the U.S. Supreme Court’s recent decision upholding a Tennessee law that blocks gender-affirming treatments for minors. The high court’s ruling reshaped the legal landscape and prompted appellate judges to revisit earlier cases involving similar policies.
The judges wrote that lawmakers may reasonably choose not to fund medical procedures they view as experimental or controversial. The surgeries referenced in the law typically include procedures designed to align physical characteristics with a person’s gender identity, such as chest reconstruction, genital surgery and facial modifications.
West Virginia officials welcomed the decision, arguing that public healthcare dollars should prioritize treatments widely considered essential. State leaders have said funds should be directed toward conditions such as cancer, heart disease and diabetes rather than procedures they consider medically uncertain.
The case reflects a broader national divide over transgender rights and medical care. More than a dozen states have adopted policies restricting Medicaid coverage for gender-affirming treatments, and several of those laws are now the subject of legal challenges.
At the federal level, the administration of Donald Trump has advanced a series of policies affecting transgender Americans, including restrictions related to gender recognition and military service. Additional proposals tied to federal healthcare funding have also triggered lawsuits that remain unresolved.
Meanwhile, advocacy groups continue to contest state limits on gender-affirming care, arguing that such restrictions deny medically necessary treatment. With cases emerging across multiple states, courts are likely to remain a central battleground in the national debate over transgender healthcare access.
